A graduate of Nankai University, Dr. Hong Chen completed her Ph.D. and postdoctoral training at the Yale University School of Medicine in the laboratory of Dr. Pietro De Camilli, where she discovered a family of endocytic adaptor proteins called epsins. Dr. Chen worked in the Cardiovascular Biology Research Program at the University of Oklahoma Health Sciences Center before moving to Boston Children's Hospital and Harvard Medical School in 2015.

Her group continues to study epsins and other endocytic adaptors for their impact on disease initiation and progression. Dr. Chen received the Irvine H. Page Young Investigator Research Award from the American Heart Association (AHA) in 2013, the AHA Established Investigator Award in 2015, the 2018 AHA Alan T Hirsch MD Mid Career Award in Vascular Medicine, and the 2024 AHA Arteriosclerosis, Thrombosis, and Vascular Biology Special Recognition Award in Atherosclerosis. She is currently serving on the AHA Arteriosclerosis, Thrombosis, and Vascular Biology Woman’s Leadership Committee and serves as a grant reviewer for the AHA and the National Institutes of Health (NIH).

Dr. Chen is always seeking highly-motivated graduate students, post-doctoral fellows, and research scientists with an interest in studying the molecular and cellular biology of disease. Candidates should have a solid background in one or more of the following areas: mouse genetics, cardiovascular biology, immunology, metabolic regulation, signal transduction, bioinformatics, rodent surgery, and mammalian physiology. Researchers are expected to have a strong work ethic, exemplary organizational and communication skills, and the ability to think critically and independently. Inquiries about potential positions should include a cover letter, curriculum vitae, and three references.